A round of equity and options financing involving 22 unnamed investors pulled in $1.6 million for BioSig Technologies, an SEC filing showed. The company did not disclose how it intends to use the proceeds and is still seeking to obtain $5.4 million in the round.
BioSig Technologies obtains $1.6M in funding round
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.